Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →18
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,476
Total Claims
$888K
Drug Cost
911
Beneficiaries
$975
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
-13%
Opioid rate vs peers
39.9% vs 45.9% avg
+102%
Cost per patient vs peers
$975 vs $483 avg
+19%
Brand preference vs peers
4.9% vs 4.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
39.9%
Opioid Rate
7,777
Opioid Claims
$378K
Opioid Cost
18.6%
Long-Acting Rate
This provider's opioid prescribing rate of 39.9% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 953 claims · $342K
Generic: 18,523 claims · $546K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl/Acetaminophen | 1,912 | $82K |
| Oxycodone Hcl | 161 | $77K |
| Oxycodone Hcl | 2,203 | $66K |
| Lidocaine | 155 | $57K |
| Hydrocodone/Acetaminophen | 1,101 | $44K |
| Buprenorphine Hcl/Naloxone Hcl | 43 | $38K |
| Gabapentin | 1,789 | $38K |
| Naloxegol Oxalate | 72 | $34K |
| Oxycodone Myristate | 50 | $33K |
| Lidocaine | 420 | $33K |
| Pregabalin | 775 | $31K |
| Tizanidine Hcl | 1,430 | $27K |
| Diclofenac Sodium | 607 | $26K |
| Buprenorphine Hcl/Naloxone Hcl | 97 | $26K |
| Linaclotide | 34 | $23K |
Prescribing Profile
61
Unique Drugs
18.0
Anomaly Score
Patient Profile
65
Avg Age
58%
Female
2.29
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About